TITLE

Neurolytic Celiac Plexus Block for Pain Control in Unresectable Pancreatic Cancer

AUTHOR(S)
Yan, Brian M.; Myers, Robert P.
PUB. DATE
February 2007
SOURCE
American Journal of Gastroenterology;Feb2007, Vol. 102 Issue 2, p430
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: A major focus of palliation in patients with unresectable pancreatic cancer is pain control. The aim of this systematic review was to examine the efficacy and safety of neurolytic celiac plexus blockade (NCPB) compared with standard treatment in randomized controlled trials (RCTs) involving patients with unresectable pancreatic cancer. METHODS: An electronic search was completed (1966 through August, 2005) for RCTs comparing NCPB versus control (standard treatment and/or sham NCPB) in patients with unresectable pancreatic cancer. The primary outcome was pain measured on a 10-point visual analogue scale (VAS). Secondary outcomes included opioid usage, adverse effects, quality of life (QOL), and survival. All outcomes were assessed at 2, 4, and 8 wk. RESULTS: Five RCTs involving 302 patients (NCPB, N = 147; control, N = 155) met the inclusion criteria. Mean age was 61.0 ± 4.3 yr. Compared with control, NCPB was associated with lower VAS scores for pain at 2, 4, and 8 wk (weighted mean difference [WMD]−0.60, 95% CI −0.82 to −0.37). Opioid usage (in mg/d oral morphine) was also reduced at 2, 4, and 8 wk (WMD −85.9, 95% CI −144.0 to −27.9). NCPB was associated with a reduction in constipation (relative risk 0.67, 95% CI 0.49–0.91), but not other adverse events. No differences in survival were observed. QOL could not be adequately analyzed due to differences in outcome scales among studies. CONCLUSIONS: In patients with unresectable pancreatic cancer, NCPB is associated with improved pain control, and reduced narcotic usage and constipation compared with standard treatment, albeit with minimal clinical significance.
ACCESSION #
23774282

 

Related Articles

  • The Comprehensive Care Team: A Description of a Controlled Trial of Care at the Beginning of the End of Life. Rabow, Michael W.; Petersen, Jane; Schanche, Karen; Dibble, Suzanne L.; McPhee, Stephen J. // Journal of Palliative Medicine;Jun2003, Vol. 6 Issue 3, p489 

    Describes the characteristics, acceptability and basic efficiency of an outpatient palliative care consultation service for patients with serious illness continuing to receive treatment for their underlying disease. Patients included in the study; Interventions; Outcome measures; Results.

  • Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. Kneuertz, Peter; Cunningham, Steven; Cameron, John; Torrez, Sergio; Tapazoglou, Nicholas; Herman, Joseph; Makary, Martin; Eckhauser, Frederic; Wang, Jingya; Hirose, Kenzo; Edil, Barish; Choti, Michael; Schulick, Richard; Wolfgang, Christopher; Pawlik, Timothy; Kneuertz, Peter J; Cunningham, Steven C; Cameron, John L; Herman, Joseph M; Makary, Martin A // Journal of Gastrointestinal Surgery;Nov2011, Vol. 15 Issue 11, p1917 

    Introduction: Routine palliative bypass has been advocated for palliation of patients with pancreatic adenocarcinoma who have inoperable disease discovered at the time of surgery. We examined trends in the relative use of palliative bypass over time with an emphasis on identifying...

  • Surgical Palliation for Pancreatic Malignancy: Practice Patterns and Predictors of Morbidity and Mortality. Bartlett, Edmund; Wachtel, Heather; Fraker, Douglas; Vollmer, Charles; Drebin, Jeffrey; Kelz, Rachel; Karakousis, Giorgos; Roses, Robert // Journal of Gastrointestinal Surgery;Jul2014, Vol. 18 Issue 7, p1292 

    Introduction: Most patients with pancreatic cancer present with, or develop, biliary or duodenal obstruction. We sought to characterize palliative surgery utilization in a contemporary cohort and identify patients at high risk of morbidity and mortality. Methods: The ACS NSQIP database...

  • Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. Choi, Younak; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue // PLoS ONE;10/5/2015, Vol. 10 Issue 10, p1 

    Introduction: Body composition has emerged as a prognostic factor in cancer patients. We investigated whether sarcopenia at diagnosis and loss of skeletal muscle during palliative chemotherapy were associated with survival in patients with pancreatic cancer. Methods: We retrospectively...

  • Education: Palliative care - Assessing anxiety in palliative care patients. Macnair, Patricia // GP: General Practitioner;5/26/2014, p17 

    The article discusses how assessing anxiety in palliative care patients can help in developing the treatment plan. Factors that contribute to anxiety in a patient receiving palliative care include fears about death, unwanted effects of treatment and physical symptoms. Also discussed are the...

  • P2–106END OF LIFE CARE AT A GYNECOLOGIC ONCOLOGY UNIT. Hasumi, Y.; Numata, A.; Kubota, K.; Tsukazaki, T.; Hashimoto, K.; Horie, K.; Yokota, H. // Annals of Oncology;Nov2013 Supplement 9, Vol. 24, pix84 

    No abstract available.

  • Efforts Aim to Curb Opioid Deaths, Injuries. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;3/25/2009, Vol. 301 Issue 12, p1213 

    The article discusses efforts by both professional organizations and governmental agencies to balance pain management amidst increasing concern over injury an death associated with use of opioid pain medications. These efforts reflected in various guidelines, requirements and recommendations...

  • Is Morbidity Influenced by Staging in the Fontan Palliation? A Single Center Review. Francios, K.; Tamim, M.; Bove, T.; De Groote, K.; De Wolf, D.; Matthys, D.; Suys, B.; Verhaaren, H.; Van Nooten, G. // Pediatric Cardiology;Jul/Aug2005, Vol. 26 Issue 4, p350 

    In a retrospective study of 32 consecutive patients undergoing a total cavopulmonary connection (TCPC), we tried to determine if the trend for decreasing age at Fontan completion and reducing the intervals between the staged procedures during the past decade was associated with a change in...

  • Locally Advanced Pancreatic Cancer: Current Therapeutic Approach. Cardenes, Higinia R.; Chiorean, Elena G.; DeWitt, John; Schmidt, Max; Loehrer, Patrick // Oncologist;Jun2006, Vol. 11 Issue 6, p612 

    Even though pancreatic cancer accounts for only 2% of all cancer diagnoses in the U.S., it is the fourth-leading cause of cancer death and one of the most difficult malignancies to manage. Because of the usually late onset of symptoms, only 10%-15% of patients present with resectable disease,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics